136 related articles for article (PubMed ID: 8553869)
1. Aggrecan degradation in osteoarthritis and rheumatoid arthritis.
Lark MW; Bayne EK; Lohmander LS
Acta Orthop Scand Suppl; 1995 Oct; 266():92-7. PubMed ID: 8553869
[No Abstract] [Full Text] [Related]
2. Keratan sulfate in body fluids in joint disease.
Thonar EJ; Masuda K; Häuselmann HJ; Uebelhart D; Lenz ME; Manicourt DH
Acta Orthop Scand Suppl; 1995 Oct; 266():103-6. PubMed ID: 8553836
[No Abstract] [Full Text] [Related]
3. The release of aggrecan fragments into synovial fluid after joint injury and in osteoarthritis.
Lohmander LS
J Rheumatol Suppl; 1995 Feb; 43():75-7. PubMed ID: 7752145
[TBL] [Abstract][Full Text] [Related]
4. Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints.
Lark MW; Bayne EK; Flanagan J; Harper CF; Hoerrner LA; Hutchinson NI; Singer II; Donatelli SA; Weidner JR; Williams HR; Mumford RA; Lohmander LS
J Clin Invest; 1997 Jul; 100(1):93-106. PubMed ID: 9202061
[TBL] [Abstract][Full Text] [Related]
5. Synovial fluid levels of tumor necrosis factor alpha and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis.
Manicourt DH; Poilvache P; Van Egeren A; Devogelaer JP; Lenz ME; Thonar EJ
Arthritis Rheum; 2000 Feb; 43(2):281-8. PubMed ID: 10693867
[TBL] [Abstract][Full Text] [Related]
6. The structure of aggrecan and its turnover in cartilage.
Hardingham TE; Fosang AJ
J Rheumatol Suppl; 1995 Feb; 43():86-90. PubMed ID: 7752148
[TBL] [Abstract][Full Text] [Related]
7. Pathways of aggrecan processing in joint tissues. Implications for disease mechanism and monitoring.
Sandy JD; Plaas AH; Koob TJ
Acta Orthop Scand Suppl; 1995 Oct; 266():26-32. PubMed ID: 8553857
[No Abstract] [Full Text] [Related]
8. Cartilage aggrecan. Biosynthesis, degradation and osteoarthritis.
Neame PJ; Sandy JD
J Fla Med Assoc; 1994 Mar; 81(3):191-3. PubMed ID: 8195777
[TBL] [Abstract][Full Text] [Related]
9. Topographic variation in biglycan and decorin synthesis by articular cartilage in the early stages of osteoarthritis: an experimental study in sheep.
Little CB; Ghosh P; Bellenger CR
J Orthop Res; 1996 May; 14(3):433-44. PubMed ID: 8676257
[TBL] [Abstract][Full Text] [Related]
10. Progressive polyarthritis induced in BALB/c mice by aggrecan from normal and osteoarthritic human cartilage.
Glant TT; Cs-Szabó G; Nagase H; Jacobs JJ; Mikecz K
Arthritis Rheum; 1998 Jun; 41(6):1007-18. PubMed ID: 9627010
[TBL] [Abstract][Full Text] [Related]
11. High levels of aggrecan aggregate components are present in synovial fluids from human knee joints with chronic injury or osteoarthrosis.
Ratcliffe A; Grelsamer RP; Kiernan H; Saed-Nejad F; Visco D
Acta Orthop Scand Suppl; 1995 Oct; 266():111-5. PubMed ID: 8553838
[No Abstract] [Full Text] [Related]
12. Aggrecan is degraded by matrix metalloproteinases in human arthritis. Evidence that matrix metalloproteinase and aggrecanase activities can be independent.
Fosang AJ; Last K; Maciewicz RA
J Clin Invest; 1996 Nov; 98(10):2292-9. PubMed ID: 8941646
[TBL] [Abstract][Full Text] [Related]
13. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
[TBL] [Abstract][Full Text] [Related]
14. Changes in joint cartilage aggrecan after knee injury and in osteoarthritis.
Lohmander LS; Ionescu M; Jugessur H; Poole AR
Arthritis Rheum; 1999 Mar; 42(3):534-44. PubMed ID: 10088777
[TBL] [Abstract][Full Text] [Related]
15. [Aggrecan].
Watanabe H
Nihon Rinsho; 2005 Aug; 63 Suppl 8():821-3. PubMed ID: 16149651
[No Abstract] [Full Text] [Related]
16. Changes in cartilage metabolism in arthritis are reflected by altered serum and synovial fluid levels of the cartilage proteoglycan aggrecan. Implications for pathogenesis.
Poole AR; Ionescu M; Swan A; Dieppe PA
J Clin Invest; 1994 Jul; 94(1):25-33. PubMed ID: 7518830
[TBL] [Abstract][Full Text] [Related]
17. Serum markers of systemic disease processes in osteoarthritis.
Thonar EJ; Masuda K; Lenz ME; Hauselmann HJ; Kuettner KE; Manicourt DH
J Rheumatol Suppl; 1995 Feb; 43():68-70. PubMed ID: 7752142
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of cartilage destruction in osteoarthritis.
Ishiguro N; Kojima T; Poole AR
Nagoya J Med Sci; 2002 Nov; 65(3-4):73-84. PubMed ID: 12580533
[TBL] [Abstract][Full Text] [Related]
19. Kinetics of release of aggrecan from explant cultures of bovine cartilage from different sources and from animals of different ages.
Ilic MZ; Haynes SR; Winter GM; Handley CJ
Acta Orthop Scand Suppl; 1995 Oct; 266():33-7. PubMed ID: 8553858
[No Abstract] [Full Text] [Related]
20. [Mechanisms of degradation of argecanes in osteoarthritic cartilage].
Lohmander LS; Lark MW; Sandy JD
Rev Prat; 1996 Mar; 46(6 Spec No):S11-S14. PubMed ID: 8731724
[No Abstract] [Full Text] [Related]
[Next] [New Search]
